Loading…
Daesang is expanding from general-purpose amino acids such as feed lysine into high-purity amino acids for pharmaceuticals and nutrition. The company completed its acquisition of German firm AMINO GmbH and consolidated its results from Q2 2026.
AMINO reported a plant utilisation rate of 105%.
The shift away from commodity feed amino acids reflects weak generic amino acid pricing and may reduce long-run commodity lysine supply growth. The direct price impact on feed markets is limited.
en.edaily.co.krKim Ji-wooAug 18, 2026Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
